Marvell–Lumentum

Marvell agreed to buy laser maker Lumentum entirely in stock, implying a $115B enterprise value at Oct 28 prices, the companies say. Regulators and both firms' shareholders must approve.

A deal between Marvell, Lumentum

Why it matters

Marvell's all-stock deal for Lumentum would give it control of Lumentum's indium-phosphide laser manufacturing, where Nvidia has non-exclusive rights to future capacity for advanced laser components. Both companies must accept remedies needed for clearance short of a 'Burdensome Condition', and Marvell owes $3.2B if the deal fails solely on regulatory grounds.

Tap a figure for the line in its source.

Marvell gives Lumentum

  • of Marvell common stock for each Lumentum common share, paid to Lumentum's stockholders: all stock, at a fixed ratio that does not move with either company's share price, with cash only in place of fractional shares
  • for each of the 2,876,415 Series A preferred shares Nvidia bought in March 2026: 4.500 Marvell shares too, or, if the holder elects for all of them, one share of a new Marvell Series B preferred meant to carry the same terms
  • termination fee if Marvell's board changes its recommendation or Marvell drops the deal for a superior proposal — or, in some cases, if within twelve months of the deal ending Marvell agrees to a deal for half or more of itself
  • regulatory termination fee if the deal dies for want of antitrust or other required approvals — a final block, a final denial, or the outside date passing, each only when nothing but those approvals is missing; never on top of the $5.8B

Lumentum gives Marvell

  • the whole company: Lumentum merges into a Marvell subsidiary and becomes wholly owned by Marvell, and its holders end up with about 33% of the combined company, fully diluted, by the companies' joint release
  • termination fee in the mirror-image cases: Lumentum's board changes its recommendation, Lumentum drops the deal for a superior proposal, or, in some cases, it agrees within twelve months to a deal for half or more of itself

Oct 28, 2026 talks reported by Bloomberg News; announced by both companies Nov 2updated Nov 21, 2026 disclosed by the parties

What happened

On November 1, 2026, Marvell agreed to buy Lumentum. Marvell sells networking chips and designs custom chips for big cloud companies. Lumentum makes lasers and other optical parts that carry data between AI chips. The agreement calls for payment entirely in Marvell stock. Lumentum shareholders would receive 4.500 Marvell shares for each Lumentum share. Lumentum shareholders would own about a third of the combined company. The joint release puts the deal's enterprise value at $115 billion, using October 28 share prices from before news of the talks broke. Enterprise value measures the value of the whole business. Lumentum's note to its employees puts the deal at about $100 billion and gives no calculation. The fixed share ratio means the deal's value moves with Marvell's stock price. That price fell after reports of the talks. Within two days of the announcement, the press put the offer at about $80–84 billion. Nvidia bought $2 billion in Lumentum preferred shares in March 2026. Those would become Marvell stock. Nvidia bought $2 billion in Marvell preferred shares the same month. The deal needs approval from both sets of stockholders, US antitrust clearance and other regulatory approvals the filed agreement does not list. Either company can walk away if the deal has yet to close by November 1, 2027. The deadline extends as late as August 1, 2028, while only approvals are missing. Marvell owes Lumentum $3.2 billion if the deal falls through solely for lack of those approvals.

Sources 32 documents — 21 SEC filings · 11 press reports

Research trail Found 125 documents and read 119 of them while checking this deal and related ones.

  1. SEC filingsec.gov
    States 9 figures: agreement · exchange ratio · preferred consideration · $5.8B termination fee marvell · $2.9B termination fee lumentum · $3.2B regulatory fee · outside date · conditions · board designees
  2. Lumentum · SEC filingsec.gov
    States 5 figures: $115B implied EV · $1,132 implied value per share · 33% ownership · combination · more than $1B synergies floor
  3. Marvell · SEC filingsec.gov
    States 4 figures: lumentum common outstanding · preferred outstanding · fee cap · remedies
  4. SEC filingsec.gov
    States fixed ratio
  5. Marvell · SEC filingsec.gov
    States supply stance
  6. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  7. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  8. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  9. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  10. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  11. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  12. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  13. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  14. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  15. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  16. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  17. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  18. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  19. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  20. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  21. SEC filingsec.gov
    Cited by the record; no single figure is quoted from it.
  22. press reportuk.marketscreener.com
    Cited by the record; no single figure is quoted from it.
  23. press reportaol.com
    Cited by the record; no single figure is quoted from it.
  24. press reportNov 2, 2026bnnbloomberg.ca
    Cited by the record; no single figure is quoted from it.
  25. press reportnews.bloomberglaw.com
    Cited by the record; no single figure is quoted from it.
  26. press reportfinance.yahoo.com
    Cited by the record; no single figure is quoted from it.
  27. press reportlightreading.com
    Cited by the record; no single figure is quoted from it.
  28. press reportNov 2, 2026fool.com
    Cited by the record; no single figure is quoted from it.
  29. press reportlivemint.com
    Cited by the record; no single figure is quoted from it.
  30. press reportNov 3, 2026nextplatform.com
    Cited by the record; no single figure is quoted from it.
  31. press reportwww-web.itiger.com
    Cited by the record; no single figure is quoted from it.
  32. press reportitiger.com
    Cited by the record; no single figure is quoted from it.

The record's own summary of its sourcing: Marvell 8-K, Item 1.01 (Nov 2 2026) and the merger agreement (EX-2.1, filed by both companies); Lumentum 8-K (Nov 2 2026) and Q1 FY27 10-Q (Nov 3 2026); the joint release and investor presentation (EX-99.1/99.2, furnished by both); the joint call transcript, both companies' letters and emails and Lumentum's employee FAQ (Rule 425, Nov 2 2026); Lumentum 8-K (Mar 2 2026) and 2026 proxy, and Marvell 8-K (Mar 31 2026), on the preferred; Reuters (via MarketScreener, AOL and BNN Bloomberg), Bloomberg (via Bloomberg Law and Yahoo Finance), Light Reading, the Motley Fool, Bloomberg Opinion (via Livemint) and The Next Platform for the contested cells (read 2026-11) · as of Nov 2026

The evidence 20 sourced figures · 4 disputes

The record's headline Marvell–Lumentum: an all-stock merger — 4.500 Marvell shares per Lumentum share, a $115B implied enterprise value at Oct 28 prices, on a ratio whose worth moves with Marvell's stock; Marvell owes $3.2B if the deal dies on regulatory grounds alone, and the $2B of Lumentum preferred Nvidia bought would become Marvell stock

Size
all stock: 4.500 MRVL per LITE share · $115B implied EV at Oct 28 unaffected prices (release; the shares' worth moves with MRVL) · fees $5.8B / $2.9B / $3.2B regulatory
When
Oct 28 2026 talks reported (Bloomberg News) → Nov 1 merger agreement signed → Nov 2 announced, three 8-Ks filed (two Marvell's, one Lumentum's), joint call → Nov 3 Lumentum's 10-Q restates the terms → HSR filings due within 15 business days of signing → stockholder votes on both sides, dates not set → expected close 1H CY2028 (joint release, Marvell) or ~12–18 months (Lumentum) → outside date Nov 1 2027, extendable to Feb 1, May 1 and Aug 1 2028
Status
signed Nov 1 2026 · announced Nov 2 · pending: both stockholder votes, HSR clearance and the other required approvals (listed only in Marvell's unfiled disclosure letter), an effective S-4 · outside date Nov 1 2027, extendable to Feb 1, May 1 and Aug 1 2028, automatically and only while regulatory conditions alone remain · expected close 1H CY2028 (joint release, Marvell) or ~12–18 months (Lumentum)
Structure
a two-step merger: Merger Sub I merges into Lumentum, which survives as a wholly owned Marvell subsidiary and then merges into Merger Sub II. All stock at a fixed 4.500 Marvell shares per Lumentum share, not adjusted for either company's price (Lumentum 10-Q). Lumentum's Series A preferred gets the same ratio on its as-converted shares (one common share each) or, by an election its holder must make for all its shares, one Marvell Series B preferred per share, 'intended to have the same terms and rights'; Lumentum's options and employees' RSUs become Marvell awards at the ratio and its PSUs time-vesting Marvell RSUs (their share counts set by performance at the close), while its non-employee directors' RSUs become Marvell shares, and its employee stock purchase plan ends just before the close. Marvell's stockholders vote on the share issuance and a charter amendment raising its authorized shares, Lumentum's on adopting the agreement. Reciprocal termination fees — $5.8B from Marvell, $2.9B from Lumentum — and a $3.2B regulatory fee from Marvell, never paid with the $5.8B (EX-2.1 §8.2(f))
Programme
Marvell–Lumentum
Parties
Marvell acquirer — issues 4.500 of its shares per Lumentum share; owes the $5.8B Marvell Termination Fee or the $3.2B Regulatory Termination Fee in their cases, never both; takes three Lumentum directors onto its board, seven directors today, Matt Murphy staying Chairman and CEO · Lumentum target — becomes a wholly owned Marvell subsidiary; owes the $2.9B Lumentum Termination Fee in the reciprocal cases; its Series A preferred, sold to Nvidia in Mar 2026 (nv-eml-lockup), converts at the same ratio or into Marvell Series B
Record
disclosed / primary source · as of Nov 2026

Flows 2 as the record states them

  • Marvell → Lumentumstock4.500 newly issued Marvell common shares for each of Lumentum's 90,684,914 common shares (Oct 29 2026), paid to its stockholders, with cash only for fractions — ≈408.1M Marvell shares for the common (our arithmetic); each of the 2,876,415 Series A preferred shares, convertible one-for-one, gets the same 4.500 Marvell shares or, by its holder's election, one Marvell Series B preferred; Lumentum's equity awards convert at the ratio, into Marvell awards except its non-employee directors' RSUs, which become Marvell shares. No cash price: the joint release's $115B is an implied enterprise value at Oct 28 unaffected prices, and the shares' worth moves with Marvell's stock
  • Lumentum → Marvellownershipall of Lumentum, which becomes a wholly owned Marvell subsidiary; Lumentum's holders would own ≈33% of the combined company and Marvell's ≈67%, fully diluted (joint release), and three Lumentum directors join Marvell's board

Resolved figures 20 each with the verbatim line from its document

  • agreement2026
    an Agreement and Plan of Merger signed Nov 1 2026 by Marvell, Lumentum and two Marvell subsidiaries formed for it (Java Merger Sub, Inc. and Java Merger Sub II, Inc.): Merger Sub I merges into Lumentum, which survives as a wholly owned subsidiary of Marvell and then merges into Merger Sub II. Both boards approved it unanimously (the agreement's recitals; each 8-K reports its own board's). Marvell's stockholders vote on the share issuance and a charter amendment raising its authorized shares, Lumentum's on adopting the agreement. Filed in full by both companies as EX-2.1, schedules omitted; Lumentum's 8-K summarizes it in the same words but for the party framing and that board paragraph
    “On November 1, 2026, Marvell Technology, Inc., a Delaware corporation (“Marvell”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Lumentum Holdings Inc., a Delaware corporation (“Lumentum”)”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • exchange-ratio4.5
    4.500 Marvell common shares for each Lumentum common share, with cash in lieu of fractions — the whole price, in stock (Lumentum's employee FAQ writes '4.5 shares'). The ratio is fixed (fixed-ratio), so what Lumentum's holders get is worth what Marvell's stock is worth at the close; the $115B and ~$1,132 a share are its value at Oct 28 unaffected prices (implied-ev, implied-value-per-share)
    “each share of common stock, par value $0.001 per share, of Lumentum (the “Lumentum Common Stock”) that is issued and outstanding immediately prior to the Effective Time, subject to certain exceptions in the Merger Agreement, will be converted into the right to receive 4.500 shares of common stock, par value $0.002 per share, of Marvell (the “Marvell Common Stock,” and such ratio, the “Exchange Ratio”)”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • fixed-ratio
    the ratio is not adjusted for either company's share price, and neither side may walk away over price moves alone; Lumentum's own 10-Q (filed Nov 3 2026, a risk factor) draws the consequence — 'the market value of the merger consideration will vary' from the announcement to the effective time. Why the $115B is a dated figure, not a price (contested deal-value, value-at-market)
    “The Exchange Ratio is fixed and will not be adjusted for changes in the market price of Marvell Common Stock or our Common Stock, and the Merger Agreement does not permit either party to terminate the Merger Agreement solely because of changes in the market price of either company’s stock.”
    Lumentum Q1 FY27 10-Q, Part II Item 1A (filed Nov 3 2026) · sec.gov
  • lumentum-common-outstanding90,684,914
    what the ratio reaches, at Lumentum's measurement date: 90,684,914 Lumentum common shares outstanding at 1:00 p.m. PT on Oct 29 2026, none in treasury, plus the 2,876,415 Series A preferred (preferred-outstanding), 203,017 shares under options, 1,565,041 under RSUs, 693,004 under PSUs at target, 282,658 reserved for the ESPP (which ends just before the close; shares bought under it by then convert as common) and 7,271,887 issuable on the convertible notes (§4.1(c)(i)). At 4.500 each, the common alone comes to ≈408.1M Marvell shares, beside Marvell's 877,987,882 outstanding at Oct 30 (§4.2(c)(i)) — our arithmetic, not the release's fully diluted 67/33
    “As of 1:00 p.m. Pacific Time on October 29, 2026 (the “Company Measurement Date”), (A) 90,684,914 shares of Company Common Stock were issued”
    Merger agreement (EX-2.1) §4.1(c)(i) · sec.gov
  • preferred-outstanding2,876,415
    all 2,876,415 Series A convertible preferred shares were still outstanding at Oct 29 2026, each 'convertible into one (1) share of Company Common Stock' (same section) — the shares Lumentum sold to Nvidia on Mar 2 2026 for $2.0B, $695.31 each (Lumentum 8-K, Item 3.02; restated in its Q1 FY27 10-Q; nv-eml-lockup). No merger document names their holder, nor does Lumentum's proxy, which counts them as 2,876,415 of its 93,459,271 voting shares at the Sep 24 2026 record date. They convert automatically on a sale to Lumentum or to anyone not an affiliate of the holder (Mar 2 8-K), so their still being outstanding reads as Nvidia, or an Nvidia affiliate, holding them — our reading
    “(C) 2,876,415 shares of Company Series A Preferred Stock, and no other shares of Company Preferred Stock, were issued and outstanding”
    Merger agreement (EX-2.1) §4.1(c)(i) · sec.gov
  • preferred-consideration
    each Series A preferred share gets the Marvell common its as-converted Lumentum common would get — one Lumentum share each at signing (the count is taken just before the close), so 4.500 Marvell shares, 12,943,867.5 for all 2,876,415 (our arithmetic; cash for the fraction) — unless its holder makes a Preferred Stock Election: irrevocable, in writing, covering all its shares, at least ten business days before Lumentum's stockholder meeting, and waiving appraisal rights (EX-2.1 §3.1). Then each share becomes one share of a new Marvell Series B Convertible Preferred instead; the form of its certificate of designation, attached to the agreement, designates 2,876,415 of them. None of the three Nov 2 8-Ks, nor the joint release, names Nvidia. Nvidia also bought Marvell preferred of its own — 2,000,000 Series A shares for $2.0B on Mar 31 2026 (Marvell 8-K; the marvell entity), all still outstanding at Oct 30 2026, each convertible into 10.8890 common (§4.2(c)(i)) — so a holder of both that elects Series B would hold two series of Marvell preferred
    “The Marvell Series B Preferred Stock is intended to have the same terms and rights as the Lumentum Series A Preferred Stock, except that each share is convertible for the Preferred Common Stock Merger Consideration.”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026); merger agreement (EX-2.1) §3.1 · sec.gov
  • termination-fee-marvell$5.8B
    the Marvell Termination Fee ('Parent Termination Fee' in the agreement, §8.2(c)): owed to Lumentum if Lumentum ends the deal after a change in the Marvell board's recommendation (or either side ends it on a failed Marvell vote at a time Lumentum could have), if Marvell ends it for a superior proposal (paid at termination), or if the deal ends on a failed Marvell vote, or on Lumentum's termination for Marvell's breach of its no-shop or proxy-and-meeting covenants, after an alternative proposal for Marvell was made public (or, in the breach case, known to its board), and within twelve months Marvell signs or completes a deal for 50% or more of its stock or of its business (by revenues, net income or assets). Twice Lumentum's fee. Paid in 'immediately available funds', as liquidated damages and the receiving side's sole and exclusive remedy, except for claims of willful breach or fraud, or under the two sides' confidentiality and clean-team agreements (§8.2(e)–(f))
    “If the Merger Agreement is terminated by Lumentum because the Marvell Board withdraws its recommendation to its stockholders regarding the Merger Agreement, or if Marvell terminates the Agreement to enter into a definitive agreement providing for a Superior Proposal, Marvell will be required to pay Lumentum a termination fee equal to $5.8 billion (the “Marvell Termination Fee”).”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • termination-fee-lumentum$2.9B
    the Lumentum Termination Fee ('Company Termination Fee', §8.2(b)): owed to Marvell in the mirror-image cases — Marvell ends the deal after a change in the Lumentum board's recommendation (or either side ends it on a failed Lumentum vote at a time Marvell could have), Lumentum ends it for a superior proposal (paid at termination), or the deal ends on a failed Lumentum vote, or on Marvell's termination for Lumentum's breach of its no-shop or proxy-and-meeting covenants, after an alternative proposal for Lumentum was made public (or, in the breach case, known to its board), and within twelve months Lumentum signs or completes a deal for 50% or more of its stock or of its business (by revenues, net income or assets). Half of Marvell's fee; Lumentum's 10-Q (Note 17) restates both, and the regulatory fee
    “Lumentum is subject to reciprocal obligations to pay a termination fee equal to $2.9 billion (the “Lumentum Termination Fee” and, each of the Marvell Termination Fee and the Lumentum Termination Fee, a “Termination Fee”) to Marvell in corresponding circumstances.”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • regulatory-fee$3.2B
    the Regulatory Termination Fee, Marvell's alone (§8.2(d)): owed if the deal ends at the outside date, on a final, non-appealable block under the HSR Act or other specified antitrust or foreign-investment laws, or on a final denial of a required approval — each only if every condition but the regulatory ones has been met (or, for those met only at the closing, could be), and a side whose own breach principally caused the failure may not end the deal on these grounds (§8.1(b)). The antitrust risk sits on the buyer; Lumentum has no counterpart fee
    “Marvell will be required to pay a termination fee equal to $3.2 billion to Lumentum (the “Regulatory Termination Fee”) if the Merger Agreement is terminated in certain circumstances related to (a) the failure to consummate the Merger prior to the Outside Date; (b) the issuance of a final and non-appealable legal restraint under the HSR Act or certain other specified antitrust or foreign investment laws; or (c) because a required regulatory approval has been denied and the denial has become final and non-appealable”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • fee-cap
    Marvell's two fees do not stack: it pays the $5.8B or the $3.2B, never both, and either at most once — so they are not a $9B exposure. A fee, once paid, is the receiving side's sole and exclusive remedy, except for claims of willful breach or fraud, or under the two sides' confidentiality and clean-team agreements
    “In no event shall any party be required to pay a Termination Fee or Regulatory Termination Fee, as applicable, on more than one occasion. In no event shall Parent be required to pay (x) the Termination Fee and the Regulatory Termination Fee or (y) the Regulatory Termination Fee on more than one occasion”
    Merger agreement (EX-2.1) §8.2(f) · sec.gov
  • outside-date2027
    the outside date: either side may walk away if the merger has not closed by 11:59 p.m. PT on Nov 1 2027, unless its own breach was the principal cause; it extends itself to Feb 1, then May 1, then Aug 1 2028, but only while antitrust or other regulatory conditions are the only ones unmet (EX-2.1 §8.1(b)(i)). A deadline, not a forecast — the companies' own expectations differ (contested expected-close)
    “if the Merger is not consummated by 11:59 p.m. Pacific Time on November 1, 2027, which may be extended to February 1, 2028, May 1, 2028 and August 1, 2028, in each case under certain circumstances if required regulatory approvals have not been obtained (the “Outside Date”)”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • conditions
    what the close waits on, the 8-K's ten conditions: Lumentum's stockholders adopting the agreement; Marvell's approving the share issuance and the charter amendment; HSR clearance and 'certain other required regulatory approvals' — named only in Section 7.1(c) of Marvell's disclosure letter, which is not filed, so no filed document lists the other jurisdictions; no legal restraint, counting one that imposes a 'Burdensome Condition' unless Marvell waives it (EX-2.1 §7.1(d)); an effective S-4; Nasdaq listing of the new shares; each side's representations true and correct (subject to certain qualifications); the charter amendment, and any Marvell Series B certificate of designation, filed in Delaware; no material adverse effect on either company; each side's obligations performed in all material respects. HSR filings are due 'in no event later than 15 business days from the date of this Agreement' (EX-2.1 §6.3(a)), and Marvell, after consulting Lumentum and considering its views in good faith, has 'final decision-making authority' over how to seek the approvals (§6.3(b))
    “The completion of the Merger is subject to customary conditions, including, among others, (a) adoption of the Merger Agreement by Lumentum’s stockholders; (b) approval of the Share Issuance and the Charter Amendment by Marvell’s stockholders; (c) the expiration or termination of any waiting period applicable to the Merger under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), and the receipt of certain other required regulatory approvals”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • remedies
    how far the companies must go to win clearance by the outside date: hold separate, sell, license or divest businesses; end, amend or assign contracts; give third parties rights, accommodations or supply commitments; accept limits on how they run their businesses — unless a remedy 'would reasonably be expected to be material (in an adverse manner)' to the combined business, or is not conditioned on the merger closing: a 'Burdensome Condition', which Marvell need not accept. Lumentum may offer no remedy without Marvell's consent, and must agree to any remedy touching its own business that Marvell directs, so long as it is conditioned on the closing; neither side may buy a competing business if that would make clearance materially less likely or slower. The agreement names supply and pricing commitments to third parties among the remedies; which any regulator will ask for, no document says
    “(C) grant any right or commercial or other accommodation to (including a modification to existing terms), or enter into any contractual or other commercial relationship with or for the benefit of, any third party (including agreeing to minimum supply, pricing or other similar commitments to third parties)”
    Merger agreement (EX-2.1) §6.3(d) · sec.gov
  • board-designees3
    three Lumentum directors join Marvell's board just after the close, chosen by Lumentum and reasonably acceptable to Marvell, and Marvell must nominate those still serving for election at its first annual meeting after the close; the joint release adds that Lumentum's CEO Michael Hurlston is one of them, that Marvell's board 'currently consists of seven directors', and that Matt Murphy will continue as Chairman and CEO of the combined company
    “Marvell will appoint three (3) individuals designated by Lumentum from among the members of the Lumentum board of directors and reasonably acceptable to Marvell to the Marvell Board”
    Marvell 8-K, Item 1.01 (filed Nov 2 2026) · sec.gov
  • implied-ev$115B
    $115B — the joint release's 'implied enterprise value' for Lumentum, at each company's unaffected closing price on Oct 28 2026, the last trading day before speculation about a deal; the talks were reported that evening (Reuters' Oct 28 wire: 'first reported by Bloomberg News'). The only deal size either company gives outside Lumentum's employee FAQ, which says 'approximately $100 billion' with no basis (deal-value). The release does not say what it adds to the value of Lumentum's shares, and none of the documents that state the terms (the 8-Ks' Item 1.01 text, the agreement, Lumentum's 10-Q) repeats it: the release reached EDGAR furnished (Lumentum's 8-K, Item 7.01; Marvell's other Nov 2 8-K, Items 2.02 and 7.01 — 'shall not be deemed “filed”'), in 8-Ks that also tick the Rule 425 box. Both companies filed those 8-Ks again the same day under Rule 425 (form 425), exhibits included: Lumentum's with the agreement, the release and the deck, Marvell's Items 2.02/7.01 report with the release and the deck, and its Item 1.01 report with the agreement; the release is in them unchanged, still 'furnished'. What the deal is worth is contested (deal-value, value-at-market)
    “The transaction has an implied enterprise value of $115 billion for Lumentum, representing approximately $1,132 per share of Lumentum common stock and a premium of approximately 23.9% based on each company’s unaffected closing share price as of October 28, 2026, the last trading day before market speculation regarding a potential transaction began.”
    Marvell–Lumentum joint release (Lumentum 8-K ex-99.1, furnished Nov 2 2026) · sec.gov
  • implied-value-per-share$1,132
    ~$1,132 per Lumentum share and a ~23.9% premium, both at Oct 28 2026 unaffected closing prices — what the ratio was worth that day, not a price fixed in cash. Light Reading's '$1.132 a share' is a misprint of this figure, not a second valuation
    “The transaction has an implied enterprise value of $115 billion for Lumentum, representing approximately $1,132 per share of Lumentum common stock and a premium of approximately 23.9% based on each company’s unaffected closing share price as of October 28, 2026, the last trading day before market speculation regarding a potential transaction began.”
    Marvell–Lumentum joint release (Lumentum 8-K ex-99.1, furnished Nov 2 2026) · sec.gov
  • ownership33%
    ≈67% to Marvell's current holders and ≈33% to Lumentum's after the close — 'on a fully diluted basis' in the release and Lumentum's employee FAQ (which writes '33%'), 'Pro forma ownership' in the deck — on a basis none of them itemizes. Not shares outstanding, and not either company's share of revenue
    “Post-closing, current Marvell stockholders will own approximately 67% of the combined company on a fully diluted basis, while Lumentum stockholders will own approximately 33%.”
    Marvell–Lumentum joint release (Lumentum 8-K ex-99.1, furnished Nov 2 2026) · sec.gov
  • combination
    what the companies say they are combining: Marvell's interconnect, switching and 'custom XPU and XPU attach' chips with Lumentum's lasers, optical transceivers, optical circuit switches and compound-semiconductor manufacturing — 'Lumentum brings advanced compound semiconductor manufacturing and process technologies, including indium phosphide (InP)', and after the close they plan to 'strengthen strategic supply'. On the joint call Lumentum's CEO described the two as already supplying the same module makers — Marvell its DSPs, drivers and TIAs, Lumentum 'laser light sources, modulators, and photodiodes' — besides the scale-out transceivers Lumentum makes itself
    “joining Marvell’s strengths in electrical and optical interconnect, network switching, custom XPU and XPU attach, and advanced semiconductor technologies with Lumentum’s expertise in high-performance lasers, optical transceivers, optical circuit switching (OCS) and specialized compound semiconductor manufacturing.”
    Marvell–Lumentum joint release (Lumentum 8-K ex-99.1, furnished Nov 2 2026); joint call transcript (Marvell Rule 425, Nov 2 2026) · sec.gov
  • synergies-floormore than $1B
    the companies' targets, not terms: 'line of sight' to more than $1B a year of run-rate cost savings, 'primarily COGS' (the deck), with no date or quantified breakdown, and accretion to Marvell's non-GAAP earnings per share in year one. The combined company's pro forma revenue and margins, which the deck and the call put on different bases, are not carried here (note)
    “provide line of sight to more than $1 billion in annual run-rate cost synergies, and is expected to be accretive to Marvell non-GAAP earnings per share in year one post-close”
    Marvell–Lumentum joint release (Lumentum 8-K ex-99.1, furnished Nov 2 2026) · sec.gov
  • supply-stance
    why now, in Marvell's CEO's words on the joint call: asked 'why now?' by Barclays' Tom O'Malley, who noted that near-term revenue is 'highly levered to some of the indium phosphide supply-demand dynamics' and asked how long those would last, he volunteered that tight supply is not the reason, calling it 'a byproduct of our thesis that we’re outlining, which is the demand is here' — the transition to scale-up, 'absolutely here'. Lumentum's CEO, on the same call: 'we plan to maintain our existing go-to-market model, offering best-in-class components and systems, while supporting the entire ecosystem'. Statements of intent, in a transcript Marvell filed under Rule 425
    “So just want to make one thing clear, that the tight supply is not the reason we’re wanting to enter this transaction now.”
    Joint call transcript (Marvell Rule 425, Nov 2 2026) · sec.gov

Contested figures 7 not reconciled — every position side by side, with its source and tier

china-approvalone entry, in its own words
the press reads China among the 'certain other required regulatory approvals' that no filed document lists (conditions): MarketWatch, carried by Tiger Brokers, says the companies 'will need China's approval to close the deal' and quotes Cantor Fitzgerald's C.J. Muse, 'We believe that China approval will be the biggest question mark'; Dow Jones, also via Tiger Brokers, reports that a Morgan Stanley team 'noted Tuesday that another concern is that the deal also needs Chinese approval'. Analysts' and reporters' reading, against filings that name only the HSR Act and leave the other approvals to an unfiled disclosure letter MarketWatch and Dow Jones via Tiger Brokers vs Marvell 8-K, Item 1.01
deal-value3 positions, side by side
$115B — the joint release's 'implied enterprise value' for Lumentum at Oct 28 unaffected prices, ~$1,132 a share (implied-ev). The only size either company gives outside Lumentum's employee FAQ (below); the release does not say what it adds to the shares' value, and the investor deck sizes only the combined company ('over ~$275B', at Oct 30 prices). The $115 billion in the wires' and trade press's headlines restates this one release Marvell–Lumentum joint release and deck (EX-99.1/99.2, furnished Nov 2 2026)
'approximately $100 billion' — Lumentum's own employee FAQ, filed under Rule 425 with its CEO's email the same day: 'an all-stock transaction valued at approximately $100 billion'. It values the purchase of 'all of the outstanding shares' but gives no basis for the figure, no price date or method, and does not mention the $115B Lumentum employee FAQ (Rule 425, Nov 2 2026)
$102.5B to 'nearly $103 billion' of equity value — Reuters ('an equity value of $102.5 billion'; '$102.54 billion' in its BNN Bloomberg version), Bloomberg ('values the equity at roughly $102.6 billion'; 'their nearly $103 billion tie-up'). No company document states an equity value as such (the FAQ's figure, for 'all of the outstanding shares', is not labelled one); these match Lumentum's common shares alone times ~$1,132 on one share count or another — Reuters' $102.54B is exactly the proxy's 90,582,856 record-date shares × $1,132, our arithmetic — so they leave out the 2,876,415 preferred shares and the 7,271,887 shares issuable on the convertible notes (lumentum-common-outstanding) Reuters via AOL and BNN Bloomberg; Bloomberg via Bloomberg Law and Yahoo Finance (Nov 2–3 2026)
value-at-marketone entry, in its own words
what the offer was worth after 'Marvell's slide since Bloomberg reported on the M&A talks' (Light Reading's words, relaying a Stifel note) — snapshots, not rival estimates, each 4.500 × a Marvell price at the time (fixed-ratio), though the two midday figures imply Marvell prices a few percent apart and neither gives the hour (our arithmetic): 'about $824 per Lumentum share, or roughly $84 billion, at midday prices' on Nov 2 (a Stifel note, via Light Reading); 'about $800 per Lumentum share, or roughly $81.2 billion in total' at Nov 2 midday (the Motley Fool); 'less than $800 per Lumentum share' (Bloomberg Opinion's Chris Hughes, via Livemint); '$80 billion in stock' (The Next Platform, Nov 3), which then adds 'another $35 billion in debts and obligations' to reach the $115B — its own subtraction, mixing a post-drop equity value with the Oct 28 enterprise value; Lumentum's 10-Q shows $1,399.6M of debt at Sep 26 2026 Stifel via Light Reading; the Motley Fool; Bloomberg Opinion via Livemint; The Next Platform (Nov 2–3 2026)
expected-close2 positions, side by side
the first half of calendar 2028 — the joint release ('expected to close in the first half of calendar year 2028'), the deck ('Expected to close 1H CY28'), Marvell's letters to its customers and suppliers and Murphy's emails to both companies' employees (Rule 425), each subject to the stockholder votes and the regulatory approvals — though the supplier letter says only 'customary closing conditions and required approvals' Joint release and deck (EX-99.1/99.2, furnished Nov 2 2026); Marvell's Rule 425 letters and emails (Nov 2 2026)
'approximately 12-18 months' — Lumentum's own employee email and FAQ, supplier email and customer email (Rule 425, the same day): about Nov 2027 to May 2028 from Nov 2 2026 (our arithmetic), opening and closing about two months before Marvell's window. One Lumentum sentence repeated, counted once. Neither expectation binds; the outside date, Nov 1 2027 extendable to Aug 1 2028, is the only date that does (outside-date) Lumentum Rule 425 communications (Nov 2 2026)

Scope note what this record leaves to other records

NOT this record (carried elsewhere or not carried): three other disclosures — Marvell's Celestial AI acquisition ($3.5B total purchase consideration at its Feb 2 2026 close) → the marvell entity note; Lumentum's FY2026 loss on debt extinguishment (the convertibles it equitized) and Nvidia's Q2 FY27 data-center revenue → not carried here, company accounts (the latter does not belong on nv-coreweave-equity). Nvidia's Lumentum preferred, purchase commitment and capacity rights stay nv-eml-lockup's; this record's cells carry only what the merger does to the preferred, and its prose points to the rest. Disputed and not carried here: the combined company's pro forma revenue and margins, given on the deck's basis (Marvell's guidance and Lumentum's latest quarter) and on a different one on the call (next-quarter guidance and analysts' consensus), and Marvell's standalone revenue basis; the share-price moves, market values and analyst price targets around the announcement; Lumentum's own figures (its sold-out horizon, unmet demand, capacity multiples, the Greensboro fab's size, customer shares, its FY2026 market value, a yen term loan's current and long-term split, and the principal of the 2029 notes it exchanged in April) and third-party optics forecasts (OCS, CPO, transceivers, InP lasers) — none a term of this deal; Marvell's other acquisitions (Celestial AI's earn-out shares, XConn's price). Not carried: the 280G tax-reimbursement agreements Lumentum entered into with its CEO and approved for its other named executive officers (Lumentum 8-K, Item 5.02); the advisers the release names (for Marvell, Qatalyst as lead financial adviser with J.P. Morgan and Goldman Sachs, Wilson Sonsini as legal adviser and FGS Global on communications; for Lumentum, Citigroup and Evercore as financial advisers, Davis Polk as legal adviser and Joele Frank on communications), two of whose deal pages, Davis Polk's and Evercore's, restate the $115B; Bloomberg's report that the two CEOs had Nvidia's Jensen Huang's blessing before striking the deal, having 'sought Huang's views during a phone call before the deal was announced', according to people familiar with the matter — no company document says so, though Hurlston told Fox Business, as Bloomberg quotes him, 'I think the reaction from Nvidia has been super positive'. Not adopted: Light Reading's '$1.132 a share' (a misprint of $1,132); the Yahoo page's '$80 Billion Deal' (a link title for a Wall Street Journal story, not Bloomberg's text); the tier-1 treatment of analysts' figures voiced on the call (J.P. Morgan's estimate of Marvell's DSP share, Bank of America's valuation framing) as company statements — the figures themselves are disputed and not carried here; they are the analysts'. Kept contested: The Next Platform's 'another $35 billion in debts and obligations', still an open question, which value-at-market sets beside the 10-Q's debt.

More between Marvell and Lumentum

The record holds no other deal between them.

Everything between Marvell and Lumentum →